Federal Circuit Confirms That PTAB Patentability Findings Do Not Have Issue-Preclusive Effect in District Court

November 11, 2025

Reading Time : 2 min

The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect to the Patent Trial and Appeal Board’s unpatentability findings regarding other claims in the same patent. In doing so, the Federal Circuit reiterated that issue preclusion does not apply where the prior factual determinations were made under a lower standard of proof.

The claims asserted by the patent owner in the district court consisted of a subset of dependent claims from two patents that were previously challenged in inter partes review proceedings. While the asserted claims were found to be not unpatentable in the prior IPRs, the PTAB did find unpatentable each of the independent claims from which the asserted claims depend. Neither party to the prior IPR proceedings appealed the PTAB’s decision.

In district court, the accused infringer moved for summary judgment of invalidity, arguing in part that issue preclusion prohibited the relitigation of validity issues as to any limitations shared between the asserted dependent claims and the related independent claims found unpatentable by the PTAB. The district court agreed, limiting the invalidity analysis to only the limitations added by the dependent claims. The court ultimately found that the additional limitations were obvious in view of the asserted prior art and granted summary judgment of invalidity as to the asserted claims.

On appeal, the Federal Circuit relied on two of its recent decisions—ParkerVision and Kroy—in concluding that the district court’s application of issue preclusion was in error. In ParkerVision, the Federal Circuit held that issue preclusion did not bar validity testimony as to the asserted method claims where the PTAB had previously found the apparatus claims of the same patent to be unpatentable. And in Kroy, it held that issue preclusion did not apply to the asserted claims even though they were “immaterially different” from those the PTAB had found unpatentable. In both decisions, the Federal Circuit clarified that the district court had erred by relying on the factual determinations made by the PTAB because a “well-known exception” to issue preclusion is where “the second action involves application of a different legal standard.” As the Federal Circuit explained in this appeal, the PTAB’s factual findings related to unpatentability should not be given issue-preclusive effect by district courts because “the standard of proof for unpatentability in an IPR (preponderance) is less than that for invalidity in district court (clear and convincing).” Because the district court in this appeal had improperly relied on the PTAB’s unpatentability findings as to the limitations shared between the independent and dependent claims, the Federal Circuit vacated the grant of summary judgment and directed the district court to revisit whether the prior art rendered obvious all limitations in the asserted claims, without considering the PTAB’s unpatentability findings.

Practice Tip: Parties should be aware that factual findings related to unpatentability determinations made by the PTAB during an inter partes review proceeding will not be afforded issue preclusive effect in the district court, even where the claims are related between the IPR and district court proceedings, because the PTAB requires a lower standard of proof than the district court’s clear and convincing evidence standard.

Inland Diamond Prods. Co. v. Cherry Optical Inc., 2025 WL 2921531 (Fed. Cir. Oct. 15, 2025)

Share This Insight

Previous Entries

IP Newsflash

November 11, 2025

The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect to the Patent Trial and Appeal Board’s unpatentability findings regarding other claims in the same patent. In doing so, the Federal Circuit reiterated that issue preclusion does not apply where the prior factual determinations were made under a lower standard of proof.

...

Read More

IP Newsflash

November 3, 2025

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

...

Read More

IP Newsflash

October 31, 2025

The District Court for the Northern District of California recently granted a defendant’s motion to bifurcate, ordering that issues related to PGR estoppel should be decided in a bench trial, while the remaining issues in the case should proceed to a jury trial.

...

Read More

IP Newsflash

October 31, 2025

The Northern District of Iowa recently held that a defendant’s motion for partial summary judgment of invalidity was barred after the PTAB issued final written decisions, regardless of when the motion was filed. The defendant filed its motion before the final written decisions were issued, but the court rejected the defendant’s argument that the timing of the motion insulated it from estoppel.

...

Read More

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.